<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The proportion of <z:chebi fb="2" ids="50699">oligosaccharide</z:chebi> chains on the Fc fragment of IgG which terminate with N-acetylglucosamine (GlcNAc) rather than <z:chebi fb="1" ids="28260">galactose</z:chebi> is increased in <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> and <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e>, and in sera from patients with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, probably because of decreased activity of a galactosyltransferase in B lymphocytes </plain></SENT>
<SENT sid="1" pm="."><plain>We have assayed the prevalence of agalactosyl <z:chebi fb="2" ids="50699">oligosaccharides</z:chebi> on IgG in sera from 67 patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (32 <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and 35 <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>) </plain></SENT>
<SENT sid="2" pm="."><plain>The prevalence of agalactosyl IgG significantly increases in the majority of Crohn's patients (19/35 patients), and correlates with the level of C-reactive protein (r = 0.79), and inversely with the concentration of serum albumin </plain></SENT>
<SENT sid="3" pm="."><plain>Sera from <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> patients show less frequent (nine of 32) and less marked rises in agalactosyl IgG, and sera with high C-reactive protein values can contain <z:mpath ids='MPATH_458'>normal</z:mpath> levels </plain></SENT>
<SENT sid="4" pm="."><plain>Thus in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> no correlation was seen between the two assays </plain></SENT>
<SENT sid="5" pm="."><plain>The diseases in which the percentage of agalactosyl IgG is raised (<z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e>, <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and some <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>) are characterised by simultaneous T cell mediated granulomatous tissue damage, and <z:hpo ids='HP_0011009'>acute</z:hpo> phase responses </plain></SENT>
<SENT sid="6" pm="."><plain>Levels are <z:mpath ids='MPATH_458'>normal</z:mpath> in less tissue damaging granulomatous conditions, including <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e>, and <z:e sem="disease" ids="C0023343" disease_type="Disease or Syndrome" abbrv="">leprosy</z:e> (except during episodes of <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum leprosum) </plain></SENT>
<SENT sid="7" pm="."><plain>We suggest therefore that a raised percentage of agalactosyl IgG is a correlate of a particular type of T cell mediated pathology which may be relevant to the pathogenesis of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
</text></document>